Earnings

August 7, 2008 at 1:18AM

LAKES ENTERTAINMENT INC.

(LACO) Develops and manages casinos and related hotel and entertainment facilities in emerging and established gaming jurisdictions. 2nd quarter FY2008, 6/29

2008 2007 % chg. Revenue $11.0 $8.1 +34.8 Income -5.2 6.6 -- Earn/share -0.21 0.25 -- 6 months

Revenue $20.5 $13.1 +56.6 Income -12.1 -3.2 -- Earn/share -0.49 -0.14 -- Figures in millions except for earnings per share.

MAKEMUSIC INC.

(MMUS) Makes music-notation and music teaching and accompaniment software. 2nd quarter FY2008, 6/30

2008 2007 % chg. Revenue $2,601.0 $2,403.0 +8.2 Income -811.0 -705.0 -- Earn/share -0.17 -0.17 -- 6 months

Revenue $6,223.0 $5,674.0 +9.7 Income -960.0 -869.0 -- Earn/share -0.21 -0.22 -- Figures in thousands except earnings per share.

MICRO COMPONENT TECHNOLOGY INC.

(MCTI) Makes automated test-handling equipment. 2nd quarter FY2008, 6/28

2008 2007 % chg. Revenue $2,963.0 $3,960.0 -25.2 Income -685.0 -280.0 -- Earn/share -0.02 -0.01 -- 6 months

Revenue $5,161.0 $7,337.0 -29.7 Income -1,801.0 -439.0 -- Earn/share -0.05 -0.01 -- Figures in thousands except earnings per share.

SOFTBRANDS INC.

(SBN) Provides software and support services for the manufacturing and hospitality industries. 3rd quarter FY2008, 6/30

2008 2007 % chg. Revenue $27.4 $23.6 +15.8 Income 0.4 -1.6 -- Net/cm -0.1 -2.1 -- Earn/share 0.00 -0.05 -- 9 months

Revenue $73.3 $70.0 +4.6 Income 0.1 -4.0 -- Net/cm -1.3 -5.4 -- Earn/share -0.03 -0.13 -- Figures in millions except for earnings per share.

XATA CORP.

(XATA) Develops mobile information systems for the fleet-trucking industry. 3rd quarter FY2008, 6/30

2008 2007 % chg. Revenue $16.2 $8.0 +102.5 Income -0.6 -0.9 -- Net/cm -0.7 -1.6 -- Earn/share -0.08 -0.21 -- 9 months

Revenue $36.0 $23.9 +50.4 Income -3.0 -2.3 -- Net/cm -3.2 -3.3 -- Earn/share -0.39 -0.41 -- Figures in millions except for earnings per share.

about the writer

More from Business

card image

A spinoff company has been formed to produce a hormone supplement that reduces lung damage, but researchers still need to convince federal regulators of its safety and effectiveness.

card image
card image